Term ends no later than Dec 8, 2031 · Medium confidence
20-year base term ends Dec 8, 2031
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Dec 8, 2011
Dec 8, 2031
Jan 26, 2016
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 8, 2011, when application 13/315,005, the earliest non-provisional in its chain, was filed (this one was filed Nov 12, 2014) | Dec 8, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Dec 8, 2031 | Medium confidence |
This family
| US 8,598,362 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,921,566 | In force Dec 2031 | Dec 2031 |
| US 9,242,936 | this patent no later than Dec 2031 | no later than Dec 2031 |
| US 9,663,492 | Lapsed on the fee record May 2025 | May 2025 |
| US 10,112,925 | Lapsed on the fee record Oct 2026 | Oct 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 1, 2015 Reel 35544, frame 502 | Li, Wei; Zhao, Robert Yongxin | ImmunoGen, Inc. | Assignment of Assignor's Interest |
| Apr 6, 2023 Reel 63282, frame 894 | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Biopharma Credit PLC | Patent Security Agreement |
| Feb 12, 2024 Reel 66553, frame 109 | Biopharma Credit PLC | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen, Inc. | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen Switzerland GmbH | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Dec 8, 2031. We will not guess the cap.